CareToLive RSS
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Spread The Word
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Donations
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
Posts Tagged ‘Joel Sharfstein’
LATEST POSTS
- 07/29/2010 - Provenge Works & Costs the Same as Chemo & Comments by Bishop
- 07/25/2010 - Setting the Record Straight
- 07/15/2010 - The Bloodshed, Bogus Threats, Birth Defects, Bashers Cover Letter
- 07/15/2010 - Provenge Is Approved But The Lies Continue
- 07/08/2010 - PROVENGE WILL BE COVERED BY MEDICARE
- 07/06/2010 - CareToLive sends a Freedom of Information Request to the Centers for Medicare & Medicaid Services
- 07/04/2010 - The Centers for Medicare and Medicaid Services are requesting comments.
- 05/20/2010 - Dr. Snuffy Myers Advocates For Provenge Treatment
- 05/03/2010 - The Real Provenge Story
- 04/29/2010 - BREAKING NEWS! PROVENGE APPROVED!
MOST POPULAR
- PROVENGE MAKING THE ROUNDS
- Sleepless in Asentar
- BREAKING NEWS! PROVENGE APPROVED!
- Michael Milken and the Prostate Cancer Foundation's Foul Balls
- The Real Provenge Story
- Dr. Snuffy Myers Advocates For Provenge Treatment
- The FDA is uncaring, the world won’t change their thought process and meanwhile Congress remains asleep at the wheel, when it comes to Provenge for the terminally ill.
- THEY'RE BACK!
- The Centers for Medicare and Medicaid Services are requesting comments.
- CareToLive sends a Freedom of Information Request to the Centers for Medicare & Medicaid Services
WHATS GOING ON
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
WE'LL BE BACK
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
FDA Makes April Fools Out of Men Still Waiting For Provenge
April 1st, 2010 | Posted by CTLSenseless years of death and delay for late stage prostate cancer patients while FDA Honchos collect huge salaries, enjoying life to the fullest.
Popularity: 31%
Tags: Care To Live, CareToLive, Dendreon, FDA, Howard Scher, Immunotherapy, Joel Sharfstein, maha hussain, Margaret Hamburg, Prostate Cancer, provenge, Richard Pazdur, sloan kettering
Posted in The Cause, The Dysfunctional FDA | Post a Comment »
CTL Sends FDA’s Sharfstein Letter Requesting Promised but Undelivered Expedited Review
March 18th, 2010 | Posted by Rory KearneyDr. Sharfstein,
Can you please check with CBER and see why it is taking them so long to make a final decision on Dendreon’s Provenge.
The pending BLA is an amended BLA that was first submitted to the FDA in 2006. Following a March 2007 AC, in which the FDA hand picked experts overwhelmingly voted for approval, CBER decided to require additional proof of efficacy. That additional proof, as set forth in the SPA, was in fact obtained by Dendreon with results being announced in April 2009 (interim data was also positive and the IDMC also recommended approval in October 2008).
Now CBER has had all the new clinical data from the IMPACT trial as of July 2009 and all the CMC data since October 2009. Despite promises from CBER to the advocacy group CareToLive and others that they would review this treatment, intended for late stage prostate cancer, expeditiously, the treatment inexplicably remains unavailable.
This review is hardly being done expeditiously. FDA has now delayed this treatment from reaching patients for 3 years.
Please inquire/help.
Kerry M. Donahue, Esq.
Counsel for CareToLive
CTL Petition for reconsideration of May 2007 decision to issue CR filed in July 2007.
Popularity: 45%
Tags: Care To Live, CareToLive, CBER, CDER, Dendreon, FDA, Joel Sharfstein, Kerry M. Donahue, Prostate Cancer, provenge
Posted in The Cause, The Dysfunctional FDA | 1 Comment »